RIT Capital Partners chair and third largest shareholder increase stakes amid backlash

The Rothschild Foundation

Valeria Martinez
clock • 2 min read

RIT Capital Partners’ chair and third largest shareholder The Rothschild Foundation have increased their stakes amid a recent backlash over the trust’s private holdings and manager payouts.

According to a stock exchange notice today (3 April), chair James Leigh-Pemberton has purchased 5,200 shares at 1,910p each, while Lord Rothschild's Foundation now has 15,390,848 shares with voting rights.  Investor demand for the £4.1bn trust has collapsed in recent months, as seen by the nearly unprecedented 21% discount it is currently trading in. The company lost investors more than 20% in share price terms last year.  RIT Capital Partners has been buying back shares nearly every day since February. Separately, a source close to the company told Investment Week that every member o...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Investment Trusts

Eleven investment trusts liquidated in first half of 2025

Eleven investment trusts liquidated in first half of 2025

Almost double 2024's total

Sorin Dojan
clock 07 July 2025 • 2 min read
Scottish Mortgage keeping activists at bay with ongoing share buybacks

Scottish Mortgage keeping activists at bay with ongoing share buybacks

£2bn spent on scheme so far

Eve Maddock-Jones
clock 04 July 2025 • 3 min read
IBT's Ailsa Craig and Marek Poszepczynski: Biotech innovation will overcome policy noise

IBT's Ailsa Craig and Marek Poszepczynski: Biotech innovation will overcome policy noise

Sector not primary target of US reforms

Ailsa Craig and Marek Poszepczynski
clock 04 July 2025 • 4 min read
Trustpilot